Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
253.24 -5.70 / -2.20%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
252.05 -1.19 / -0.47%
Volume: 600.00

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+3.47% 3 years+41.21%
3 months+19.23% 5 years+37.09%
1 year+81.04% Since inception+19.46%
Data through 07/29/2015

Quote Details

Previous close$258.94
Open day’s range250.32 – 261.46
Net asset value (NAV)258.51 (07/28/2015)
Daily volume1,245,555
Average volume (3 months)1,192,198
Data as of 4:00pm ET, 07/29/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+37.09%+26.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.421.74
Net assets$2.7B$2.0B
Average market cap$2.2B$37.5B
Average P/E--25.5
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RDUS Radius Health Inc1.32%
KYTH KYTHERA Biopharmaceuticals Inc1.28%
ZIOP ZIOPHARM Oncology Inc1.19%
NVAX Novavax Inc1.16%
EPZM Epizyme Inc1.15%
BCRX BioCryst Pharmaceuticals Inc1.10%
PRTA Prothena Corporation PLC1.09%
RARE Ultragenyx Pharmaceutical Inc1.08%
CMRX Chimerix Inc1.06%
MDXG MiMedx Group Inc1.06%